News | News By Subject | News by Disease News By Date | Search News

Kidney Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Comeback Kid Exelixis (EXEL) Could Pose a Huge Threat to Biotech Giants Bristol-Myers Squibb (BMY) and Pfizer (PFE)     10/18/2016
Bay Area Exelixis (EXEL)' Cabometyx Beats the Pants Off Pfizer (PFE)'s Sutent in Mid-Stage Kidney Cancer Study     10/11/2016
Comeback Kid Exelixis (EXEL)' Touts Positive Phase III Cancer Data     2/1/2016
Top 10 Best-Selling Biotech Drugs     10/2/2015
Nearly-Dead AVEO Oncology (AVEO)'s Stock Jumps on Positive European Regulatory Promises     6/5/2015
Thrasos Scores $21M to Complete Phase II THR-184, Expands Renal Portfolio     4/1/2015
EXCLUSIVE: Resverlogix Corporation (RVX.TO) CEO Says Experimental Cardiac Drug Holds High Hopes, As Biotech Booms     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Akebia Therapeutics, Inc. (AKBA)'s Lead Drug AKB-6548 Succeeds In Mid-Stage Trial     10/27/2014
Concert Pharmaceuticals, Inc. (CNCE) Presents Positive 48-Week Results From Phase 2 Clinical Trial Of CTP-499 In Diabetic Kidney Disease     4/28/2014
FDA Accepts Veloxis Pharmaceuticals A/S (VELO)'s New Drug Application For Envarsus®     3/14/2014
La Jolla Pharmaceutical Company (LJPC) Soars As Kidney Drug Is Effective In Phase 2 Study     3/13/2014
AMAG Pharmaceuticals, Inc. (AMAG) Drops As The FDA Turns Down Application For Iron Deficiency Drug Feraheme®     1/22/2014

News from Around the Web
What's Next For Bristol-Myers Squibb (BMY) After Another Opdivo Setback?     8/23/2017
Popular Acid Reflux Meds May Boost Kidney Disease Risk, Johns Hopkins University Study     10/28/2015
Teen's Nosebleed Leads To Parents' Cancer Diagnosis     7/23/2015
Tomatoes, Watermelon, And Papaya May Lower Cancer Risk In Women, Wayne State University Study     3/4/2015
Mayo Clinic Researchers Reveal Treasure Trove Of Genes Key To Kidney Cancer     7/2/2014
Mayo Clinic Researchers Say Gene In Brain Linked To Kidney Cancer     6/25/2014
Experimental Drug Prolongs Life Span In Mice, and Northwestern University and Tohoku University Study     5/5/2014
First Responders Exposed To September 11 Debris Have Damaged Kidneys, Mount Sinai School of Medicine Study     11/11/2013
New Compound Holds High Promise in Battling Kidney Cancer, University of California, Riverside Study     2/20/2013
Commonly Used Pain Pills Increase Kidney Cancer Risk in Study, Brigham and Women's Hospital Reveals     9/14/2011
Heavy Smoking Tied to Advanced Kidney Cancer, Duke University Study     5/16/2011
Agent Orange Linked to Kidney Cancer: Veterans Affairs Medical Center Study     5/16/2011
Blood Pressure May Hint at Kidney Cancer Outcome, Cleveland Clinic Study     5/6/2011
American Society of Nephrology: Lipid Combo Cuts CV Risk in Kidney Disease, Oxford University Study     11/22/2010
Mayo Clinic Researchers Find Genetic Secrets to Common Kidney Cancer     5/19/2010

Press Releases
Acceleron Pharma Ditches Dalantercept After Failure Of Phase II Kidney Cancer Study     6/13/2017
Peloton Therapeutics Initiates Patient Dosing In Phase II Study Of PT2385 For Von Hippel-Lindau Disease-Associated Kidney Cancer     5/11/2017
Liquid Biopsy Offers A New Way To Target Kidney Cancer, City of Hope Study Suggests     2/17/2017
Xcell Biosciences Initiates New Collaborations With UCSF Researchers Studying Effectiveness Of Immunotherapy In Urologic Cancers     9/22/2016
Peloton Therapeutics Announces Dual Publications Of HIF-2a Antagonism In Kidney Cancer In The Journal Nature     9/6/2016
ASCO2016: Peloton Therapeutics Presents Clinical Data On First-In-Class Oral HIF-2a Inhibitor In Patients With Advanced Kidney Cancer At 2016 ASCO Annual Meeting     6/6/2016
PROOF Centre Collaboration Focuses On Prognostic Biomarkers For Chronic Kidney Disease     2/11/2016
Exelixis (EXEL) Announces European Medicines Agency Acceptance Of Marketing Authorization Application For Cabozantinib As A Treatment Foradvanced Renal Cell Carcinoma     1/29/2016
Rosetta Genomics Ltd. (ROSG) Granted U.S. Patent Allowance For Use Of Gene Expression Signature For Classification Of Kidney Tumors     1/25/2016
Entia Biosciences Begins Clinical Study Of Proprietary Ergod2 Medical Food Product To Demonstrate Improved Health For The More Than 25 Million Chronic Kidney Disease Sufferers In The U.S.     12/21/2015
Resverlogix (RVX.TO) Presents Important New Data At The Annual American Society of Nephrology Kidney Week Conference     11/9/2015
FibroGen, Inc. (FGEN) Release: Phase II Data For Investigational Orally Active HIF-PHI Roxadustat (FG-4592) Show Anemia Correction In Incident Dialysis Chronic Kidney Disease Patients Regardless Of Iron Repletion Status, Iron Supplementation Regimen, Or Dialysis Modality     10/23/2015
Exelixis (EXEL) Initiates Rolling Submission Of U.S. New Drug Application For Cabozantinib For The Treatment Of Advanced Kidney Cancer     10/22/2015
Shire (SHPG)'s CINRYZE Receives FDA Fast Track Designation     10/13/2015
Hutchison China MediTech (Chi-Med) Release: Savolitinib Completes Enrolment For Phase II Clinical Trial In Papillary Renal Cell Carcinoma     10/13/2015